
Singapore: Public Comments on Revised Draft of GN-20: Guidance on Clinical Evaluation
The Health Sciences Authority (HSA) Singapore revised Guidance Document: GN-20 Guidance on Clinical Evaluation. The updates reflect their current position on the use of real-world data in medical device clinical evidence as well as clarify related contents with IMDRF guidelines. The HSA is currently soliciting industry comments for this revision.




